7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Aytu Biopharma, Inc
(NASDAQ:AYTU) 

AYTU stock logo

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Nates...

Founded: 2002
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Aytu Biopharma Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 019.6139.2358.8478.4598.07117.68137.29
Aytu Biopharma Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 017.0534.151.1568.285.25102.3119.35
Aytu Biopharma Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 018.7237.4556.1774.993.62112.35131.07
Aytu Biopharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -178.75-153.05-127.36-101.67-75.97-50.28-24.591.11
Aytu Biopharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -178.75-153.05-127.36-101.67-75.97-50.28-24.591.11
Aytu Biopharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 017.9135.8353.7471.6689.57107.48125.4
Aytu Biopharma P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 04.629.2413.8618.4923.1127.7332.35
Aytu Biopharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -38.89-33.33-27.78-22.22-16.67-11.11-5.560
Aytu Biopharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 08.7817.5626.3435.1343.9152.6961.47
No extra charts and metrics for this ticker.